School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA, 30332, USA.
Parker H. Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, GA, 30332, USA.
Adv Mater. 2024 Mar;36(9):e2307678. doi: 10.1002/adma.202307678. Epub 2023 Dec 6.
Human intestinal organoids (HIOs) derived from pluripotent stem cells or adult stem cell biopsies represent a powerful platform to study human development, drug testing, and disease modeling in vitro, and serve as a cell source for tissue regeneration and therapeutic advances in vivo. Synthetic hydrogels can be engineered to serve as analogs of the extracellular matrix to support HIO growth and differentiation. These hydrogels allow for tuning the mechanical and biochemical properties of the matrix, offering an advantage over biologically derived hydrogels such as Matrigel. Human intestinal organoids have been used for repopulating transplantable intestinal grafts and for in vivo delivery to an injured intestinal site. The use of synthetic hydrogels for in vitro culture and for in vivo delivery is expected to significantly increase the relevance of human intestinal organoids for drug screening, disease modeling, and therapeutic applications.
人肠类器官(HIOs)来源于多能干细胞或成人干细胞活检,代表了一个强大的平台,可用于研究人类发育、药物测试和体外疾病建模,并可作为组织再生和体内治疗进展的细胞来源。合成水凝胶可被设计为模拟细胞外基质,以支持 HIO 的生长和分化。这些水凝胶可以调整基质的力学和生化特性,这是优于生物衍生水凝胶(如 Matrigel)的优势。人肠类器官已被用于再植入可移植的肠移植物,并用于损伤的肠部位的体内给药。合成水凝胶用于体外培养和体内给药的应用有望极大地提高人肠类器官在药物筛选、疾病建模和治疗应用中的相关性。